Abbvie Inc. $7,033,871 Acelyrin, Inc. $198,000 Neumora Therapeutics, Inc. $4,253,574 Abbvie Inc. $7,033,871 Acelyrin, Inc. $198,000 Neumora Therapeutics, Inc. $4,253,574